These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 16299687

  • 1. Risk factors and underlying cardiovascular diseases in incident ESRD patients.
    Di Benedetto A, Marcelli D, D'Andrea A, Cice G, D'Isa S, Cappabianca F, Pacchiano G, D'Amato R, Oggero AR, Bonanno D, Pergamo O, Calabrò R.
    J Nephrol; 2005; 18(5):592-8. PubMed ID: 16299687
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter.
    Levin A, Djurdjev O, Barrett B, Burgess E, Carlisle E, Ethier J, Jindal K, Mendelssohn D, Tobe S, Singer J, Thompson C.
    Am J Kidney Dis; 2001 Dec; 38(6):1398-407. PubMed ID: 11728982
    [Abstract] [Full Text] [Related]

  • 3. Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?
    Shah DS, Polkinghorne KR, Pellicano R, Kerr PG.
    Nephrology (Carlton); 2008 Dec; 13(8):667-71. PubMed ID: 18761627
    [Abstract] [Full Text] [Related]

  • 4. The Diamant Alpin Dialysis cohort study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patients.
    Pernod G, Bosson JL, Golshayan D, Barro C, Alloatti S, Turc-Baron C, Quarello F, Jeantet A, Von Albertini B, Forêt M, Lauren G, Cordonnier D, Piccoli G, Wauters JP, Diamant Alpin Collaborative Dialysis Study Group.
    J Nephrol; 2004 Dec; 17(1):66-75. PubMed ID: 15151261
    [Abstract] [Full Text] [Related]

  • 5. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.
    Albert MA, Glynn RJ, Buring J, Ridker PM.
    Circulation; 2006 Dec 12; 114(24):2619-26. PubMed ID: 17116764
    [Abstract] [Full Text] [Related]

  • 6. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients.
    de Mutsert R, Grootendorst DC, Axelsson J, Boeschoten EW, Krediet RT, Dekker FW, NECOSAD Study Group.
    Nephrol Dial Transplant; 2008 Sep 12; 23(9):2957-64. PubMed ID: 18400817
    [Abstract] [Full Text] [Related]

  • 7. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA, Koro CE, Chan W, Bowlin SJ, Sprecher DL.
    Clin Ther; 2006 Feb 12; 28(2):243-50. PubMed ID: 16678645
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J, López-Gómez JM, Aljama P.
    Nefrologia; 2005 Feb 12; 25(3):297-306. PubMed ID: 16053011
    [Abstract] [Full Text] [Related]

  • 10. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H, Qureshi AR, Heimbürger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B.
    Am J Kidney Dis; 2006 Jan 12; 47(1):139-48. PubMed ID: 16377395
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD, Gillett M, Holmes M, Ogden E.
    Public Health; 2006 Dec 12; 120(12):1140-8. PubMed ID: 17084425
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Epidemiology of cardiovascular risk in Chinese chronic kidney disease patients].
    Hou FF, Ma ZG, Mei CL, Rong S, Huang SM, Liu XR, Yuan WJ, Guo YS, Wang L, He Q, Wang XL, Sang XH, Li XL.
    Zhonghua Yi Xue Za Zhi; 2005 Mar 23; 85(11):753-9. PubMed ID: 15949381
    [Abstract] [Full Text] [Related]

  • 15. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
    Noordzij M, Korevaar JC, Bos WJ, Boeschoten EW, Dekker FW, Bossuyt PM, Krediet RT.
    Nephrol Dial Transplant; 2006 Sep 23; 21(9):2513-20. PubMed ID: 16799173
    [Abstract] [Full Text] [Related]

  • 16. [Coronary heart disease risk factors in Croatia and worldwide: results of the Interheart study].
    Carević V, Rumboldt M, Rumboldt Z, Interheart Investigators.
    Acta Med Croatica; 2007 Jun 23; 61(3):299-306. PubMed ID: 17629106
    [Abstract] [Full Text] [Related]

  • 17. Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy.
    Stenvinkel P, Diczfalusy U, Lindholm B, Heimbürger O.
    Nephrol Dial Transplant; 2004 Apr 23; 19(4):972-6. PubMed ID: 15031358
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.